BRU investigator receives life-saving technology award

Posted by mb543 at Jul 12, 2016 01:35 PM |

Andre Ng Lifemap awardA BRU Investigator has scooped a top award for his life-saving research.

Professor André Ng from the University of Leicester received the Inventors Award from the European Heart Rhythm Association (EHRA).

The prize recognises Professor Ng’s novel method which identifies patients who are at risk of sudden cardiac death (SCD) and could potentially save thousands of lives.

The research work leading up to this has been supported by the University of Leicester and Leicester Hospitals at the NIHR Leicester Cardiovascular Biomedical Research Unit.

Professor Ng said: "I am absolutely thrilled! To have been shortlisted as one of the three finalists among strong applications from many centres in Europe was great and to have won the award was magnificent.”

“The award is a recognition of the work not only in its scientific value, but also the innovation behind the invention and commercialisation potential.

“The EHRA Inventors Award would help progress the technology to the next level and make it closer for us to develop this into a valuable clinical tool to improve patient care as a commercially available product.”

Professor Ng was given an award consisting of a diploma and a financial grant €5,000 which can be used for a course in entrepreneurship or comparable, in order to support him in further developing their invention.

The new technology tests people to see which of those at risk of SCD would benefit from an implantable cardioverter defibrillator (ICD).

The ICD delivers a shock to the heart when the rhythm becomes erratic.

Across the globe, over three million people a year are killed by SCD.

The Inventors Award was created to innovative clinicians and scientists working in the field of arrhythmia and electrophysiology.

The innovation project should relate to the field of EP and address any novel approach, which may include software, hardware and drugs.

Currently, there is no effective means to assess the risk of SCD in many patient groups.

The use of this new technology may mean that a real difference will be made to the assessment and treatment of patients, which could help to save lives.

Share this page:

Athena SWAN Silver Award